Cervical cancer, which epidemiologically resembles a non-infectious form
of venereal disease, is a predominant contributor to cancer-related deaths in females
across the globe. The HPV-16 and HPV-18 strains of the human papillomavirus, as
well as STDs, are the prime causes of cervical cancer. In low-income female
communities, it ranks as the second most frequent malignancy. Primary, secondary, and
tertiary preventative strategies are included for the management of cervix cancer. The
primary defense against cervical cancer includes guarding against HPV infection. One
of the key preventative strategies for cervical cancer involves immunizing females
between the ages of 9 and 14 with the HPV vaccine before they begin sexual activity.
Secondary cervical cancer prevention requires examination and a chemotherapy
regimen. Testing asymptomatic females in the target population (pre-cancer risk for the
cervix) is a component of determining the susceptibility to cervical carcinoma. Tertiary
disease prevention includes the provision of palliative care and treatments for cervical
cancer. Tertiary care encompasses surgical interventions, radiation treatment,
chemotherapy, and supportive care for patients. To ensure that the community takes
responsibility for preventing the incidences of cervical cancer, community
mobilization, awareness of health, and counseling are essential. It is important to
routinely monitor and assess key program indicators for cervical cancer prophylaxis
and curb it.
Keywords: Chemotherapy, Cervical cancer, HPV vaccine, Intraepithelial neoplasia, Pap smear, Radiotherapy, Sexually transmitted HPV
